|
gptkbp:instance_of
|
gptkb:pharmaceuticals
|
|
gptkbp:approves
|
gptkb:1994
|
|
gptkbp:body_shape
|
oval
|
|
gptkbp:brand
|
gptkb:Glucophage_XR
gptkb:Glucophage
|
|
gptkbp:category
|
Category B
|
|
gptkbp:class
|
biguanide
|
|
gptkbp:clinical_trial
|
studies on efficacy
studies on safety
|
|
gptkbp:color
|
gptkb:white
|
|
gptkbp:contraindication
|
metabolic acidosis
severe renal impairment
|
|
gptkbp:dosage_form
|
gptkb:tablet
once daily
|
|
gptkbp:food_interaction
|
take with food
|
|
gptkbp:formulation
|
extended-release tablet
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Glucophage XR
|
|
gptkbp:imprints
|
BMS 1000
BMS 500
BMS 750
|
|
gptkbp:ingredients
|
gptkb:metformin
|
|
gptkbp:interacts_with
|
gptkb:beer
other antidiabetic medications
|
|
gptkbp:long_term_use
|
requires monitoring
|
|
gptkbp:manufacturer
|
gptkb:Bristol-Myers_Squibb
|
|
gptkbp:mechanism_of_action
|
increases insulin sensitivity
decreases hepatic glucose production
|
|
gptkbp:packaging
|
gptkb:bottle
|
|
gptkbp:previous_name
|
gptkb:metformin_hydrochloride
|
|
gptkbp:requires
|
prescription only
|
|
gptkbp:route_of_administration
|
oral
|
|
gptkbp:side_effect
|
nausea
stomach upset
diarrhea
|
|
gptkbp:storage
|
room temperature
|
|
gptkbp:strength
|
500 mg
1000 mg
750 mg
|
|
gptkbp:symptoms
|
none reported
|
|
gptkbp:type_of_care
|
important for effectiveness
|
|
gptkbp:used_for
|
type 2 diabetes
|
|
gptkbp:bfsParent
|
gptkb:Metformin
|
|
gptkbp:bfsLayer
|
5
|